Loading provider…
Loading provider…
Hematology & Oncology Physician in Cleveland, OH
NPI: 1346269230Primary Employer
Health Source of Boardman
healthsourcechiro.com
HQ Phone
Get MD Joseph's Phone Numberphone_androidMobile
Get MD Joseph's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
MUC1 is expressed at high frequency in early-stage basal-like triple-negative breast cancer.
Authors: Halle Moore, G Thomas Budd, Alberto Montero
Journal: Clin Cancer Res
Authors: Charles Shapiro, Tessa Cigler, Dawn Hershman, Kerin Adelson, Yelena Novik, Susan Tannenbaum, Paula Klein, Ellis Levine, Michael Naughton, G Thomas Budd, Antoinette Tan, Eleni Andreopoulou, Kevin Kalinsky, Miguel Villalona Calero, Joseph Sparano
Journal: NPJ Breast Cancer
Publication Date: 2016-12-14
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: PROCEDURE: Magnetic Resonance Imaging, DRUG: Docetaxel, OTHER: Quality-of-Life Assessment, DRUG: Atezolizumab, DRUG: Paclitaxel, OTHER: Placebo Administration, PROCEDURE: Computed Tomography, BIOLOGICAL: Trastuzumab, PROCEDURE: Biopsy, PROCEDURE: Bone Scan, BIOLOGICAL: Pertuzumab
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Carvedilol, OTHER: Patient Observation
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Pembrolizumab, PROCEDURE: Biospecimen Collection, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, OTHER: Patient Observation